Speech apraxia
Gene: BPTF
In-house proband now published. Individual with CAS and dysarthria and de novo BPTF variant (c.3157_3158delAA; p.(Lys1053Glufs*12)) (Van Niel et al., 2026; PMID: 41530369), Validated diagnostic finding from VCGS clinical NATA pipeline
Glinton et al. (2021, PMID: 3352209) report 22/26 (85%) individuals with BPTF variants with unspecified speech delay.Created: 20 May 2026, 3:59 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies (MIM#617755)
Publications
An in-house (as yet unpublished) CAS proband with a pathogenic variant.
Sources: Expert Review, Expert listCreated: 12 Sep 2024, 6:29 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, MIM# 617755
Gene: bptf has been classified as Red List (Low Evidence).
Gene: bptf has been classified as Red List (Low Evidence).
gene: BPTF was added gene: BPTF was added to Speech apraxia. Sources: Expert Review,Expert list Mode of inheritance for gene: BPTF was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: BPTF were set to Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, MIM# 617755 Review for gene: BPTF was set to RED